CLASS III ONGOING Drug recall · Reported 8 Jan 2025 · FDA Enforcement Report

Carboxymethylcellulose Sodium Ophthalmic Solution recalled by AvKARE

AvKARE is recalling Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, distributed nationwide in the US. The recall was initiated on 18 Dec 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 0160, Exp. Date April 26 2026
NDC50268-068
Quantity recalled16,677 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0175-2025
FDA event ID
96032
Recalling firm
AvKARE, Pulaski, TN
Manufacturer
AvPAK
Classification
Class III
Status
Ongoing
Recall initiated
18 Dec 2024
FDA classified
2 Jan 2025
Reported
8 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Drug class
Eye Drops

Timeline

18 Dec 2024Recall initiated by company
2 Jan 2025Classified by FDA+15 days
8 Jan 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

LABELING: LABEL MIX-UP

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by: AvKARE, Pulaski, TN, 38478, NDC 50268-068-15.

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

LABELING: LABEL MIX-UP

Which lots are affected?

Lot #: 0160, Exp. Date April 26 2026

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 96032
ReportedClassRecallCompanyReasonWhere
CLASS IIIPolyvinyl Alcohol Ophthalmic Solution recalled by AvKAREPolyvinyl AlcoholAvKAREPackaging DefectsNationwide

More recalls from AvKARE

All 62
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Carboxymethylcellulose recalls

All 17